Bank of America Merrill Lynch Healthcare Conference (Vical) - May 15, 2012 - Anticipated top-line data from P3 SPA pivotal trial for melanoma in late 2012
Anticipated P3 top line data • Melanoma
|
|
Allovectin
-- -- --
Top-line data from Phase 3 trial
-- -- --
|